Madrigal Pharmaceuticals, Inc.

NASDAQ (USD): Madrigal Pharmaceuticals, Inc. (MDGL)

Last Price

316.98

Today's Change

+13.49 (4.44%)

Day's Change

304.35 - 320.00

Trading Volume

97,178

Overview

Market Cap

6 Billion

Shares Outstanding

21 Million

Avg Volume

373,118

Avg Price (50 Days)

245.14

Avg Price (200 Days)

246.67

PE Ratio

-12.71

EPS

-25.02

Earnings Announcement

26-Feb-2025

Previous Close

303.49

Open

305.00

Day's Range

304.35 - 320.0

Year Range

168.25 - 368.29

Trading Volume

98,021

Price Change Highlight

1 Day Change

4.75%

5 Day Change

2.24%

1 Month Change

48.25%

3 Month Change

23.83%

6 Month Change

44.46%

Ytd Change

40.13%

1 Year Change

67.27%

3 Year Change

285.81%

5 Year Change

211.21%

10 Year Change

194.90%

Max Change

-0.08%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment